RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Elevation Oncology Stock

Elevation Oncology ROA 2024

Elevation Oncology ROA

-0.51

Ticker

ELEV

ISIN

US28623U1016

In 2024, Elevation Oncology's return on assets (ROA) was -0.51, a -49.17% increase from the -1.01 ROA in the previous year.

Elevation Oncology Aktienanalyse

What does Elevation Oncology do?

Elevation Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Elevation Oncology's Return on Assets (ROA)

Elevation Oncology's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Elevation Oncology's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Elevation Oncology's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Elevation Oncology’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Elevation Oncology stock

What is the Return on Assets (ROA) of Elevation Oncology this year?

The Return on Assets (ROA) of Elevation Oncology is -0.51 undefined this year.

What was the ROA of Elevation Oncology compared to the previous year?

The ROA of Elevation Oncology has increased by -49.17% compared to the previous year.

What consequences do high ROA have for investors of Elevation Oncology?

A high ROA is advantageous for investors of Elevation Oncology, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Elevation Oncology?

A low ROA can be unfavorable for investors of Elevation Oncology as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Elevation Oncology affect the company?

An increase in ROA of Elevation Oncology can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Elevation Oncology impact the company?

A reduction in the ROA of Elevation Oncology can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Elevation Oncology?

Some factors that can influence the ROA of Elevation Oncology include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Elevation Oncology important for investors?

The ROA of Elevation Oncology is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Elevation Oncology take to improve ROA?

To improve ROA, Elevation Oncology can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Elevation Oncology pay?

Over the past 12 months, Elevation Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Elevation Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Elevation Oncology?

The current dividend yield of Elevation Oncology is .

When does Elevation Oncology pay dividends?

Elevation Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Elevation Oncology?

Elevation Oncology paid dividends every year for the past 0 years.

What is the dividend of Elevation Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Elevation Oncology located?

Elevation Oncology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Elevation Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Elevation Oncology from 7/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/27/2024.

When did Elevation Oncology pay the last dividend?

The last dividend was paid out on 7/27/2024.

What was the dividend of Elevation Oncology in the year 2023?

In the year 2023, Elevation Oncology distributed 0 USD as dividends.

In which currency does Elevation Oncology pay out the dividend?

The dividends of Elevation Oncology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Elevation Oncology

Our stock analysis for Elevation Oncology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elevation Oncology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.